Poxvirus:
Infections with avian poxvirus have been recorded from a variety of wild and pet birds. Some isolates are primarily infectious for only the homologous host, whereas others are infectious for one or more additional species. Classification is usually based on host pathogenicity studies. Canarypox infection is usually severe, and mortality sometimes approaches 100%. Cutaneous lesions may develop, as may systemic infection with cytoplasmic inclusion bodies detected in lesions on histological examination. A commercial canarypox virus vaccine for canaries is available in the USA. Poxvirus infection in psittacines may also be severe, especially in blue-fronted Amazon parrots. Poxviruses isolated from psittacines appear to be unrelated to poxviruses of other avian species.
Aminoglycosides:
Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms. Gentamicin is the most commonly used aminoglycoside, but amikacin may be particularly effective against resistant organisms. Aminoglycosides are used in the treatment of severe infections of the abdomen and urinary tract, as well as bacteremia and endocarditis. They are also used for prophylaxis, especially against endocarditis. Resistance is rare but increasing in frequency. Avoiding prolonged use, volume depletion and concomitant administration of other potentially nephrotoxic agents decreases the risk of toxicity. Single daily dosing of aminoglycosides is possible because of their rapid concentration-dependent killing and post-antibiotic effect and has the potential for decreased toxicity. Single daily dosing of aminoglycosides appears to be safe, efficacious and cost effective. In certain clinical situations, such as patients with endocarditis or pediatric patients, traditional multiple dosing is still usually recommended.
The first aminoglycoside, streptomycin, was isolated from Streptomyces griseus in 1943. Neomycin, isolated from Streptomyces fradiae, had better activity than streptomycin against aerobic gram-negative bacilli but, because of its formidable toxicity, could not safely be used systemically. Gentamicin, isolated from Micromonospora in 1963, was a breakthrough in the treatment of gram-negative bacillary infections, including those caused by Pseudomonas aeruginosa. Other aminoglycosides were subsequently developed, including amikacin (Amikin), netilmicin (Netromycin) and tobramycin (Nebcin), which are all currently available for systemic use in the United States.
Amikacin has been implicated in nephron (kidney tubules) damage in psittacines.
D3 toxicity can & does cause calcification of the kidney in parrots.